Literature DB >> 11501797

Determination of moclobemide, paroxetine, and fluvoxamine in tablets by HPLC.

R Skibiński1, G Misztal.   

Abstract

A simple, accurate high performance liquid chromatography procedure is presented in order to determine moclobemide in Aurorix-tablets, paroxetine in Seroxat-tablets and fluvoxamine in Fevarin tablets. These drugs were chromatographed on a Nova-Pak C18, (dp = 4 microm), 150x3.9 mm i.d. column using methanol/phosphate butter adjusted to pH 2.65 with phosphoric acid (7:3, v/v) as the mobile phase to determining of the moclobemide and methanol/tetrahydrofuran/phosphate buffer at pH 2.65 (53:5:4, v/v) for determining of paroxetine and fluvoxamine. The detection was carried at 235 nm. The method was tested for linearity over the range 5-50 microg/ml. The relative standard deviation for moclobemide is 1.16, but for paroxetine and fluvoxamine is less than 1% (0.25 and 0.46 respectively).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501797

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

1.  A Stability Indicating HPLC Method for the Determination of Fluvoxamine in Pharmaceutical Dosage Forms.

Authors:  Effat Souri; Hassan Donyayi; Reza Ahmad Khaniha; Maliheh Barazandeh Tehrani
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

2.  Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid.

Authors:  Hamid Reza Akbari Hasanjani; Mahmoud Reza Sohrabi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.